GT
INSP icon

Glenmede Trust’s Inspire Medical Systems INSP Stock Holding History

Glenmede Trust’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-81,495
Closed -$4.2M – 1533
2026
Q1 		$4.2M Sell
81,495
-491
-0.6% -$34.4K 0.02% 469
2025
Q4 		$7.56M Buy
+81,986
New +$7.84M 0.04% 393

Other funds holding INSP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Glenmede Trust's INSP Position: Q2 2026 in Review

Glenmede Trust sold out of Inspire Medical Systems (INSP) in Q2 2026, closing a stake of 81,495 shares — an estimated $4.2M sold.

Glenmede Trust first reported a position in INSP in Q4 2025 and held it in 2 quarters. The position peaked at $7.56M in Q4 2025. 275 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • Glenmede Trust reported no remaining Inspire Medical Systems position as of Q2 2026 after selling out during the quarter.
  • Glenmede Trust sold 81,495 Inspire Medical Systems shares in Q2 2026, an estimated $4.2M.
  • Glenmede Trust first reported a position in Inspire Medical Systems in Q4 2025 and held it in 2 quarters.
  • Glenmede Trust's Inspire Medical Systems position peaked at $7.56M in Q4 2025.
  • 275 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Glenmede Trust's 13F filing for Q2 2026, filed 10 Aug 2026.